Targeted Formulations for Clinical Excellence
Delivering research-driven therapeutic solutions with verifiable bioequivalence and comprehensive regulatory compliance for global healthcare systems.
Supporting Oncology Care Through Product-Focused Solutions
Hattersley Pharmaceuticals focuses on serving oncology centres with product information and pharmaceutical solutions aligned with approved product information and applicable regulatory requirements.
Our Primary Focus
Oncology
We recognise the importance of reliable product information and responsible medicine use in oncology care. Our focus is on supporting healthcare professionals and oncology centres with relevant product details, prescribing information and appropriate safety guidance.
Our Commitment to Responsible Healthcare
We believe that accurate product information, appropriate medical supervision and attention to patient safety are essential to responsible pharmaceutical practice.
We aim to provide clear product information to healthcare professionals and institutional partners while adhering to applicable regulatory requirements.
Our Product Portfolio
ONCOMEG-OS | Megestrol Acetate Oral Suspension
ONCOMEG-OS contains Megestrol Acetate at a strength of 40 mg/mL and is supplied in a 120 mL pack. Its use should follow the approved product information and the direction of a registered medical practitioner.
Prescription medicine. To be used under the supervision of a registered medical practitioner.
Our Commitment
Unwavering Dedication to Patient Safety and Bioequivalence
Every Hattersley formulation undergoes stringent validation, ensuring consistent efficacy and complete batch traceability from research to patient.
Connect with Our Medical Science Liaisons
Our team is ready to provide specialized clinical discussions and detailed product information tailored to your institutional needs.